Deleted Tweets From Scott Gottlieb, R-D.C.

Fortunately, while women were underrepresented, the trials were large enough w/adequate #’s of women to determine safety and effectiveness. #FDA continues taking steps to encourage greater inclusion of women in trials, including OWH’s Diverse Women in Clinical Trials Initiative. https://t.co/20d9Sg2vqn

FDA can make better product safety decisions if women are included in clinical trials. OWH works withe #FDA's medical product centers to advocate for such inclusion but ensuring a sufficient number of women in trials is an ongoing effort https://t.co/7rw1ltTT5a.

The inclusion of women in clinical trials is much better today but challenges remain. Women now make up a large portion of the clinical trial population but are less commonly included in trials for certain kinds of conditions, including certain kinds of heart disease. https://t.co/k4lb4VHdSL

Also, while most of FDA’s women’s health initiatives are product specific, the #FDA plays an outsize role when it comes to mammography, which produces low-dose x-ray picture of the breast – an important tool to detect breast cancer in its early, most treatable stages. https://t.co/aoYjsSEPrC

Transparency is one way to encourage greater inclusion. Check out our Drug Trials Snapshots - information about who participated in clinical trials supporting a drug’s approval and whether there are any demographic differences in benefits or side effects https://t.co/jeshlVL15y. https://t.co/MyoBPe0IGg

The MQSA was intended to address mammography quality concerns and it’s been a huge success. Image quality has improved, radiation dose has declined and equipment violations have all but disappeared. Today the 5-year breast cancer survival rate is 95%-99%, up from 84% in 1995.

Under the 1992 Mammography Quality Standards Act (MQSA), #FDA oversees mammography machines and regulates training for people who provide the scans. All mammography facilities must be accredited, certified by FDA or a state certifier and inspected annually https://t.co/E03Ig8KW1N https://t.co/dZzQuYXsJ9

Although I’ve been focusing on medical products, we're also advancing our food safety and nutrition work, such as our joint advice w/ EPA on making informed choices about eating fish for women who are pregnant, may become pregnant or are breastfeeding https://t.co/dZUN59ZSpR. https://t.co/nktV9BDAC3

Whether it’s funding scientific research, examining policy approaches to vexing safety issues, or launching public education campaigns, you can be assured that this is a top commitment for us, and #FDA is fully engaged in promoting and protecting the health of the nation’s women https://t.co/euQki9iqsL

It’s concerning that many women who qualify for a mammogram don’t go for regular screening, in part due to common myths like mammograms “are painful” or “cause cancer.” During this Breast Cancer Awareness month, I urge women to check the facts https://t.co/jejpjxvRV4. https://t.co/DGz5Xvquky

We know that cancer is harder to find in women with dense breasts – some women may need other imaging tests. Breast density reporting is already required in some states. Expanding this nationwide will empower patients and providers to make more informed health decisions.

We’re now moving to update/modernize our oversight to capitalize on a # of important advances, including the increased use of digital imaging, revised screening recommendations from the @CDCgov and need for uniform nation-wide breast density reporting https://t.co/QhFEtXc8rH.

RT @CBSHealth: 100,000 young children in the U.S. haven't gotten any vaccines at all, putting them -- and others -- at serious ris… https://t.co/vs2RsSJ36H

RT @SGottliebFDA: Women have different health needs than men. In today’s #FDA #SUNDAYTWEETORIAL I’m going to talk about how the FDA i… https://t.co/twEfSH77l8

RT @SGottliebFDA: The #FDA recently hosted a conference on the influence of sex and gender in opioid and nicotine use to increase awa… https://t.co/dwg0K6akFn

@hbottemiller @POLITICOPro @liz_crampton Hey @hbottemiller, maybe I should have trademarked it? ™️

RT @FDATobacco: Smoking cigarettes causes coughing, wheezing, and shortness of breath. Help keep your lungs healthy, so you can he… https://t.co/5tw02tXmzn

#FDA’s forthcoming proposal to update and modernize our mammography oversight is meant to capitalize on a number of important advances, including the need for more uniform, nation-wide breast density reporting: https://t.co/AJc7FAqDlK https://t.co/mN651mee1B

RT @SecretarySonny: Kicking off 2-day joint meeting w/@US_FDA about cell cultured meat and how the new technology will be regulated. Mu… https://t.co/r6SGjVXXWq

RT @FDATobacco: This October we are celebrating #HealthyLungMonth. Smoking can damage the lungs, which can turn the lung tissue a d… https://t.co/tEGdpggycR

Fortunately, while women were underrepresented, the trials were large enough w/adequate #’s of women to determine safety and effectiveness. #FDA continues taking steps to encourage greater inclusion of women in trials, including OWH’s Diverse Women in Clinical Trials Initiative. https://t.co/20d9Sg2vqn

FDA can make better product safety decisions if women are included in clinical trials. OWH works withe #FDA's medical product centers to advocate for such inclusion but ensuring a sufficient number of women in trials is an ongoing effort https://t.co/7rw1ltTT5a.

The inclusion of women in clinical trials is much better today but challenges remain. Women now make up a large portion of the clinical trial population but are less commonly included in trials for certain kinds of conditions, including certain kinds of heart disease. https://t.co/k4lb4VHdSL

Also, while most of FDA’s women’s health initiatives are product specific, the #FDA plays an outsize role when it comes to mammography, which produces low-dose x-ray picture of the breast – an important tool to detect breast cancer in its early, most treatable stages. https://t.co/aoYjsSEPrC

Transparency is one way to encourage greater inclusion. Check out our Drug Trials Snapshots - information about who participated in clinical trials supporting a drug’s approval and whether there are any demographic differences in benefits or side effects https://t.co/jeshlVL15y. https://t.co/MyoBPe0IGg

The MQSA was intended to address mammography quality concerns and it’s been a huge success. Image quality has improved, radiation dose has declined and equipment violations have all but disappeared. Today the 5-year breast cancer survival rate is 95%-99%, up from 84% in 1995.

Under the 1992 Mammography Quality Standards Act (MQSA), #FDA oversees mammography machines and regulates training for people who provide the scans. All mammography facilities must be accredited, certified by FDA or a state certifier and inspected annually https://t.co/E03Ig8KW1N https://t.co/dZzQuYXsJ9

Although I’ve been focusing on medical products, we're also advancing our food safety and nutrition work, such as our joint advice w/ EPA on making informed choices about eating fish for women who are pregnant, may become pregnant or are breastfeeding https://t.co/dZUN59ZSpR. https://t.co/nktV9BDAC3

Whether it’s funding scientific research, examining policy approaches to vexing safety issues, or launching public education campaigns, you can be assured that this is a top commitment for us, and #FDA is fully engaged in promoting and protecting the health of the nation’s women https://t.co/euQki9iqsL

It’s concerning that many women who qualify for a mammogram don’t go for regular screening, in part due to common myths like mammograms “are painful” or “cause cancer.” During this Breast Cancer Awareness month, I urge women to check the facts https://t.co/jejpjxvRV4. https://t.co/DGz5Xvquky

We know that cancer is harder to find in women with dense breasts – some women may need other imaging tests. Breast density reporting is already required in some states. Expanding this nationwide will empower patients and providers to make more informed health decisions.

We’re now moving to update/modernize our oversight to capitalize on a # of important advances, including the increased use of digital imaging, revised screening recommendations from the @CDCgov and need for uniform nation-wide breast density reporting https://t.co/QhFEtXc8rH.

RT @CBSHealth: 100,000 young children in the U.S. haven't gotten any vaccines at all, putting them -- and others -- at serious ris… https://t.co/vs2RsSJ36H

RT @SGottliebFDA: Women have different health needs than men. In today’s #FDA #SUNDAYTWEETORIAL I’m going to talk about how the FDA i… https://t.co/twEfSH77l8

RT @SGottliebFDA: The #FDA recently hosted a conference on the influence of sex and gender in opioid and nicotine use to increase awa… https://t.co/dwg0K6akFn

@hbottemiller @POLITICOPro @liz_crampton Hey @hbottemiller, maybe I should have trademarked it? ™️

RT @FDATobacco: Smoking cigarettes causes coughing, wheezing, and shortness of breath. Help keep your lungs healthy, so you can he… https://t.co/5tw02tXmzn

#FDA’s forthcoming proposal to update and modernize our mammography oversight is meant to capitalize on a number of important advances, including the need for more uniform, nation-wide breast density reporting: https://t.co/AJc7FAqDlK https://t.co/mN651mee1B

RT @SecretarySonny: Kicking off 2-day joint meeting w/@US_FDA about cell cultured meat and how the new technology will be regulated. Mu… https://t.co/r6SGjVXXWq

RT @FDATobacco: This October we are celebrating #HealthyLungMonth. Smoking can damage the lungs, which can turn the lung tissue a d… https://t.co/tEGdpggycR